Will Next Generation Obesity Drugs make Bariatric Surgery Obsolete?

Show notes

Watch the full debate to hear two leading experts tackle one of the most talked-about questions in obesity care. In this episode, Prof. Francesco Rubino (King’s College London) and Dr. Louis Aronne (Cornell Medical College) join Vivienne Parry to debate whether next-generation medications will eventually make obesity surgery obsolete.

The conversation covers: •The evolving role of bariatric surgery in an era of powerful GLP-1-based therapies •What new medications and minimally invasive procedures could reshape obesity care •The economic, clinical, and patient-preference factors influencing treatment choices •Why obesity management is moving toward multi-modal, integrated care models •The importance of tackling stigma and ensuring equitable access to treatment

For deeper insights into incretin science, clinical outcomes, and next-generation therapies, learn more about our expert speakers:

  1. Francesco Rubino
  2. Louis Aronne

New comment

Your name or nickname, will be shown publicly
At least 10 characters long
By submitting your comment you agree that the content of the field "Name or nickname" will be stored and shown publicly next to your comment. Using your real name is optional.